Oncolytics Biotech Inc. appointed Matt Coffey as president and CEO, effective immediately.
Coffey was named the company's interim president and CEO in November 2016.
Oncolytics Biotech's interim CEO to head company on a permanent basis
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Oncolytics Biotech Inc. appointed Matt Coffey as president and CEO, effective immediately.
Coffey was named the company's interim president and CEO in November 2016.